Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress

NEXT STORY
Vaccinex Reports First Quarter 2019 Financial Results and Provides Corporate Update
PREV STORY
BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myovant Sciences Appoints Lauren Merendino as Chief Commercial Officer

author_avatar
NASDAQ Market News

Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer

author_avatar
NASDAQ Market News

Polyphor to Take Part in Panel Discussion on Novel Oncology Targets at the LifeSci Partners 10th Annual Healthcare Corporate Access Event

author_avatar
NASDAQ Market News